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ABSTRACT: The aim of the study was to evaluate the impact of
clinical severity and placental weight upon fetal lactacidemia in
intrauterine growth restricted (IUGR) pregnancies. Seventy pregnan-
cies complicated by IUGR were compared with 70 normal (appro-
priate for gestational age, AGA) pregnancies at the time of elective
cesarean section. IUGR pregnancies were divided according to clin-
ical severity in three groups: Group 1 had normal fetal heart rate
(FHR) and normal pulsatility index of the umbilical artery (PI);
Group 2 had normal FHR and abnormal PI; and Group 3 had
abnormal FHR and PI. No cases with severe lactacidemia had
placental weights 250 g. Forty-four fetuses had placental weight
250 g: Twenty-four had severe lactacidemia and all were Group 2
and 3, whereas 20 had normal umbilical artery lac (lactate) (and small
placentas) regardless of the clinical severity. Gestational age, fetal
and placental weights, F/P ratios, uv (umbilical vein) and ua lac and
ua oxygen content and pH were significantly decreased in fetuses
with small placentas and high lactate. There was a significant rela-
tionship between fetal and placental weight in AGA and IUGR.
However, IUGR fetuses with placental weight 250 g exhibited an
F/P ratio significantly lower than that in AGA fetuses suggesting that
IUGR may be due to a reduction of placental function per gram of
tissue. (Pediatr Res 59: 570–574, 2006)
Lactate represents the end product of anaerobic metabolismof glucose. However, many experimental as well as
studies in human pregnancies both in vivo (1–3) and in vitro
(4,5) have shown that lactate is produced within the placenta
and delivered into both the maternal and umbilical circulation
where it serves as source of carbon for fetal growth. This has
been clearly demonstrated by studies in pregnant sheep where
fetal utilization of lactate at term is three times higher than the
umbilical uptake (approximately 4 mg/kg/min) in the well-
oxygenated fetus (6). The fetal liver is the organ with the
highest lactate consumption and liver lactate uptake almost
equals umbilical uptake: lactate is then used for oxidation and
synthesis of fatty acid and glycogen (7). In human pregnan-
cies, fetal lactate concentration is higher than maternal (2,3).
Many clinical studies at the time of delivery (i.e. under
non-steady stressed conditions) have shown that umbilical
venous and arterial lactate concentrations as well as the um-
bilical venoarterial concentration difference correlate with
Apgar scores both at 1= and 5= (8,9). In clinical studies
performed at the time of spontaneous delivery, lactate con-
centrations have been shown to represent a much more reli-
able marker of fetal acidosis compared with pH measurements
(10,11). However, difficulties in sample management have
limited its widespread clinical application. Recently the char-
acteristics of L-lactic acid transport across the human placen-
tal syncytiotrophoblast have been described (12,13) as has
been done for human erythrocytes (14), hepatocytes (15),
intestinal brush border membrane (16,17) and skeletal-muscle
(18). These studies indicate the presence of an H dependent
carrier which is similar both on the basal membrane (maternal
side) (12) and on the brush border membrane (fetal side) (13)
of human trophoblast although the difference in sensitivity to
phloretine and DIDS suggest that distinct transporters may
exist on each side of the trophoblast. The transporters on the
basal surface of the trophoblast may provide a driving force
for L-lactic acid transport across the basal membrane of the
trophoblast into the trophoblast. Since accumulation of L-
lactic acid can cause acidosis in the fetus, this system may
prevent lactate from accumulating in the fetal compartment.
No such studies have been performed in placental of intra-
uterine growth restricted pregnancies. It is clear, though, that
under normal conditions, the fetal hepatic uptake of lactate is
its major route of disposal.
The present study was performed to explore the relationship
between fetal lactate concentration in IUGR fetuses of differ-
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ent clinical severity and to correlate it to fetal oxygenation and
placental weight. This study was also prompted by recent
reports of decreased fetal hepatic perfusion in IUGR pregnan-
cies (19). Such an occurrence might alter fetal hepatic lactate
uptake and increase the risk of fetal acidosis.
MATERIALS AND METHODS
The study was performed in the Department of Obstetrics and Gynecology
of the University of Milan, DMSD San Paolo, Italy. The protocol of the study
was approved by the San Paolo Ethical Committee and by the Colorado
Multiple Institutional Review Board of the University of Colorado Health
Sciences Center. Informed consent was obtained from all patients.
We studied 140 patients at the time of elective cesarean section: Seventy
patients had uneventful pregnancies and 70 had pregnancies complicated by
intrauterine growth restriction (IUGR). The clinical indication for cesarean
section in the normal group was repeat cesarean section or previous uterine
surgery (38 cases), breech presentation (28 cases) and placenta previa (four
cases). In IUGR pregnancies the clinical indications to cesarean section are
presented in Table 1, according to clinical severity. Gestational age at delivery
was calculated by the last menstrual period and confirmed by an ultrasound
examination performed within 20 wk. Normal growth appropriate for gesta-
tional age (AGA) and IUGR were confirmed at birth according to the Italian
birth weight-gestational age standard (20). All IUGR fetuses were below the
10th percentile, 41 were below the fifth. No chromosomal abnormalities or
fetal malformations were present at birth.
IUGR pregnancies were divided into three groups by clinical severity
based on a classification previously proposed (21) and based on the Pulsatility
Index of the umbilical artery (PI) measured by Doppler velocimetry and on
the fetal heart rate (FHR) recording, obtained within 12 h from cesarean
section. The methodology for PI measurement and FHR analysis have been
described elsewhere (21). According to PI and FHR, 23 IUGR pregnancies
were classified as Group 1; 20 as Group 2; and 27 as Group 3.
In all cases, cesarean section was performed under general anesthesia after
an overnight fast of at least ten hours: none of the patients had entered labor.
During surgery the patients were ventilated with nitrous oxide with a con-
centration of 60% nitrous oxide and 40% oxygen. Maternal blood pressure
was carefully monitored and no hypotensive episodes were detected. Imme-
diately after fetal extraction, the umbilical cord was doubly clamped and
blood was withdrawn from the UA and vein. Maternal blood was collected
simultaneously from the radial artery in 67 AGA and 63 IUGR. After
delivery, the placenta was collected and weighted trimmed.
Table 2 presents the mean gestational age, fetal and placental weight and
fetal/placental weight ratio of AGA pregnancies and IUGR according to
clinical severity. It also presents the mean percentage reduction of fetal
abdominal circumference, measured by ultrasound within 24 h from delivery,
for each IUGR group calculated using the 50th percentile of AGA fetuses as
100%.
Maternal and fetal blood samples were collected in heparinized 2.5 and 1
mL syringes respectively, that were immediately sealed and stored on ice. pH,
pO2 mmHg, pCO2 mmHg were determined on a Radiometer ABL 330
analyzer (Radiometer, Copenhagen DK). Hb concentration g/dL and oxygen
saturation % were measured in duplicate on a radiometer OSM-3 oxymeter
and oxygen content (O2C) was calculated from these parameters according to
the formula:
O2C (mM)  Hb Concentration g/dL Oxygen Saturation 0.05982.
Lactate concentration was determined in duplicate on a Yellow Spring
Analyzer (YS 23L, Yellow Springs, OH). All analyses were completed within
10 min from sampling.
To quantitate fetal net utilization of lactate relative to oxygen uptake,
umbilical lactate oxygen quotient (LOQ) was calculated as:
LOQ  Lactate Umbilical Venoarterial Difference (mM) 3/O2C Umbilical
Venoarterial Difference (mM).
All the results are presented as mean  SEM. The significance of the
differences among groups were calculated with the t test for unpaired samples
and with the 2 test after testing for normal distribution of data with an F-test.
Regression analyses were carried out by the least squares methods. Differ-
ences between slopes were tested using multiple linear regression analysis.
P-values were considered significant at p  0.05.
RESULTS
Lactate concentration in AGA and IUGR. The mean lac-
tate concentration in the maternal artery and in the umbilical
vein and artery are presented in Fig. 1A. Figure 1B presents
the umbilical venoarterial lactate concentration difference and
LOQ and the maternal arterial-umbilical arterial lactate con-
centration difference in AGA and in the three groups of IUGR
pregnancies according to clinical severity. Among these clin-
ical groups, AGA and Group 1 were not significantly different.
Group 2 and 3 had progressively more severe lactacidemia.
Figure 1B depicts the fact that there were significant differ-
ences in the umbilical venoarterial concentration difference for
lactate but this was not reflected in the LOQ.
Lactate concentration, fetal and placental weights. Figure
2 presents the relationship between umbilical arterial lactate
concentration and placental weight. No cases with severe
lactic acidemia (umbilical arterial lactate concentration 2.18
mM) could be detected for placental weights  250 g. This
placental weight was chosen as the lowest placental weight
found in AGA fetuses. In those fetuses with a placental weight
 250 g, 24 (55%) had severe lactacidemia and all were
Group 2 and 3 fetuses. The remaining 20 fetuses (45%) had
normal arterial lactate concentrations. Surprisingly, all three
groups were included in this group with small placentas and
normal lactate concentrations regardless of the clinical sever-
ity. However, there were no infants with normal velocimetry
(AGA and Group 1) who had elevated lactate concentrations,
regardless of placental size. Table 3 shows that gestational
age, fetal and placental weights, fetal/placental (F/P) ratios,
umbilical venous and arterial O2C and pH were all signifi-
cantly decreased whereas BD was significantly increased in
fetuses with small placentas and high lactate. Also, the per-
centage of absent/reverse end diastolic flow in the UA was
significantly increased in these fetuses.
Figure 3 shows the relationship between umbilical arterial
lactate concentration and O2C. The relationship is nonlinear.
Below an arterial O2 content of 2 mM, only the fetuses of
Groups 2 and 3 developed severe lactacidemia.
The relationship between fetal and placental weight in
presented in Fig. 4. There is a significant relationship between
these two variables in each group (AGA: fetal weight (FWt)
2615  1.2 placental weight (PWt); R2  0.12; p  0.003,
IUGR: FWt  407  4.4 PWt; R2  0.62; p  0.001).
However, it is clear from this figure that IUGR pregnancies
represent two different populations. There are fetuses whose
Table 1. Clinical indication to cesarean section in IUGR
pregnancies according to clinical severity
IUGR 1 IUGR 2 IUGR 3
Fetal indication
Breech presentation 6 1
IUGR 10 10





PIH  CTG 3
Total 23 20 27
CTG, cardiotocography; PIH, pregnancy induced hypertension.
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placental weight is within the normal range ( 250 g) and still
are growth-retarded. These cases exhibit an F/P ratio, which is
significantly lower than that in AGA fetuses (5.5  0.3 versus
7.1  0.2; p  0.001) suggesting that intrauterine growth
restriction may be due to placental insufficiency; i.e. placental
function per gram of tissue is reduced.
DISCUSSION
The aim of this study was to determine the relationships
among three variables; severity of growth restriction, placental
weight and feto/placental lactate metabolism. Previously,
many studies have analyzed fetal lactate concentrations in
different clinical situations. These studies have shown that lactate
concentrations present a reliable assessment of fetal acidosis with
a good correlation with neonatal outcome (8,9,10).
This study has demonstrated significant differences in feto/
placental lactate metabolism between normal and IUGR preg-
nancies. For fetuses with birth weights  10° centile, both
maternal and fetal lactate concentrations are increased com-
pared with normal pregnancies. This is not surprising since
IUGR is a clinical situation at highest risk of intrauterine
hypoxia and/or acidosis. However, we have previously re-
ported that velocimetry measurements of the UA coupled with
the analysis of the fetal heart rate can distinguish groups of
different clinical severity among IUGR fetuses. This is valid
not only for parameters commonly related to fetal well being
(21) (i.e. fetal oxygenation and acid base balance) but also for
glucose (22) and amino acid metabolism (23). These studies,
as well as the present study, have demonstrated that, in IUGR
fetuses with normal PI and normal FHR there are no signifi-
cant differences when compared with normally grown fetuses
Table 2. Gestational age at delivery and fetal and placental weights in AGA and IUGR pregnancies according to clinical severity
AGA IUGR 1 IUGR 2 IUGR 3 AGA vs 1 AGA vs 2 AGA vs 3 1 vs 2 1 vs 3 2 vs 3
Gestational age (weeks) 38.2 0.1 37 0.3 34.2 0.6 31 0.5 * * * * * *
Fetal weight (grams) 3189 45 2108 79 1478 111 953 82 * * * * * *
Placental weight (grams) 470 13 332 22 248 25 163 10 * * * 0.02 * *
F/P ratio 7.1 0.2 6.8 0.3 6.3 0.4 5.9 0.4 0.4 0.06 0.002 0.4 0.09 0.4
% reduction AC 14.6 1.1 14.5 1.6 16.2 1.2 1 0.4 0.4
The % reduction of the abdominal circumference US measurement in IUGR is also shown.
AC, abdominal circumference.
* p  0.001.
Figure 1. A) Lactate concentration in the maternal artery (AGA  67; IUGR
Group 1 22; IUGR Group 2 17; IUGR Group 3 23) and umbilical vein
and artery (AGA  70; IUGR Group 1  23; IUGR Group 2  20; IUGR
Group 3  27) in AGA pregnancies and IUGR according to clinical severity.
B) Umbilical venoarterial lactate concentration difference (AGA  70; IUGR
Group 1  23; IUGR Group 2  20; IUGR Group 3  27), lactate/oxygen
quotient (AGA  70; IUGR Group 1  22; IUGR Group 2  19; IUGR
Group 3  25), and maternal arterial-umbilical arterial concentration differ-
ence (AGA  67; IUGR Group 1  22; IUGR Group 2  17; IUGR Group
3  23) in AGA and IUGR pregnancies. AGA: open bars; IUGR Group 1:
hatched bars; IUGR Group 2: gray bars; IUGR Group 3: black bars. Values
are mean  SE.
Figure 2. Relationship between umbilical arterial lactate concentration and
placental weight in AGA pregnancies and IUGR according to clinical sever-
ity. The linear regression line (hatched) was calculated for AGA and IUGR
Group 1 pooled together, since the regression analysis of each separately were
not different (p 0.8). UA lac (mM) 1.4-0.0003 PWt (grams); R2 0.006;
p  0.5. On the contrary the data of IUGR Group 2 and 3 fitted a curvilinear
model: UA lac (mM)  154.5PWt (grams)-0.8 R2  0.37; p  0.01. The
horizontal dotted line represents the value for umbilical arterial lactate
concentration (2.18 mM) that is 2 SD above the mean in AGA. AGA (n 
70): open circles; IUGR Group 1 (n  23): grey circles; IUGR Group 2 (n 
20) black squares; IUGR Group 3 (n  27): black triangles.
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except for a reduced leucine enrichment ratio (23). In contrast,
IUGR fetuses of Group 2 and 3 have a higher incidence of
hypoxia, acidosis, and hypoglycemia.
The present study also demonstrates that fetal/placental
lactate metabolism is altered in these pregnancies according to
the clinical severity as defined previously and that these
changes in lactate metabolism correlate with placental weight.
Gestational age remains a confounding variable in all such
studies. Often the most severe cases, (Group 3), are the earliest
in onset and these are the cases with the highest incidence of
lactacidemia. Figure 2 brings out the importance of the pla-
cental weight in clarifying which Group 2 and 3 fetuses are
severely acidotic. IUGR cases with normal placental weights
maintain lactate concentrations within the normal limits. We
have previously shown that lactate concentration does not
change during gestation (21) which permits comparison of
fetuses at different gestational ages.
The present study confirms our previous observations (2) of
acid base balance in IUGR with a much larger data set and
adds placental weight to the analysis, namely that lactate is
significantly increased in IUGR fetuses with abnormal PI. A
previous study had clearly established that there is a signifi-
cant reduction in umbilical blood flow in Group 2 and 3 IUGR
pregnancies. This is true even when umbilical blood flow is
expressed per kg fetal weight (19). Thus, it is not surprising
that the present study demonstrates a significantly reduced O2
content in the fetal arterial circulation in Group 2 and 3 IUGR
pregnancies as well as a significant lactacidemia.
Finally, it is important to note in Fig. 3 that50% of Group
1 pregnancies had reduced umbilical arterial O2 content at
delivery. This should be interpreted cautiously since previous
studies from our group (21,24) and several other groups
(25,26) have shown that this is not the case when the samples
are collected at cordocentesis, reflecting normal steady state
conditions. The present data were collected at cesarean section
where the stress of anesthesia and surgery may impact umbil-
ical blood flow and fetal oxygenation.
Table 3. Gestational age at delivery, fetal and placental weights and oxygenation and acid base balance values (mean  SE) in IUGR
whose placental weight was 250 grams and umbilical arterial lactate concentration above or below 2SD of AGA
UA lactate  2SD UA lactate  2SD P-value
Gestational age (weeks) 33.7 0.7 30.8  0.6 0.002
Fetal weight (grams) 1388 105 959  96 0.004
Placental weight (grams) 188.4 8.3 155 9 0.01
F/P 7.2 0.4 6.1  0.4 0.05
ARED Flow 7/20 17/24 0.03
UV O2C (mM) 5.1  0.3 4  0.2 0.001
UA O2C (mM) 1.7  0.2 1.2  0.1 0.04
UV-UA O2C difference (mM) 3.3  0.4 2.8  0.2 ns
UV pH 7.319  0.006 7.254 0.012 0.001
UA pH 7.274  0.008 7.202 0.014 0.001
UV BD 2  0.3 5.2  0.7 0.001
UA BD 2  0.4 5.9  0.7 0.001
UV lactate concentration (mM) 1.27 0.08 3.4 0.2 0.001
UA lactate concentration (mM) 1.4 0.09 3.8  0.3 0.001
UV-UA lactate concentration difference (mM) 0.13  0.05 0.42  0.06 0.001
LOQ 0.13  0.06 0.45  0.07 0.002
Maternal artery – UA lactate (mM) 0.6  0.1 2.4  0.3 0.001
M lactate concentration (mM) 0.8 0.05 1.5  0.2 0.006
ARED flow, absent/reverse end diastolic flow.
Figure 3. Relationship between umbilical arterial lactate concentration and
O2C in AGA pregnancies and IUGR according to clinical severity. As in Fig.
2, the regression line was calculated for AGA and IUGR of Group 1 pooled
together since the two were not different (p 0.8). UA lac (mM) 1.62-0.13
UA cont (mM); R2  0.12; p  0.001. AGA (n  70): open circles; IUGR
Group 1 (n 22): grey circles; IUGR Group 2 (n 19) black squares; IUGR
Group 3 (n  25): black triangles.
Figure 4. Relationship between fetal and placental weight in AGA pregnan-
cies and IUGR according to clinical severity. The regression line for AGA is
presented: Fetal weight (grams)  2615  1.2 placental weight (grams); R2
 0.12; p  0.003. AGA (n  70): open circles; IUGR Group 1 (n  23):
grey circles; IUGR Group 2 (n 20) black squares; IUGR Group 3 (n 27):
black triangles.
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The key role of the placental size in sorting out these IUGR
infants with the highest risk of lactic acid is shown in Fig. 4.
The functional role of the placenta in IUGR pregnancies is
still under investigation. Many studies have shown that IUGR
placentas are smaller than AGA placentas (27,28). Based on
this observation, many investigators have hypothesized that
asymmetrical IUGR is determined by placental hypoplasia
(reduction of placental mass). However, the present study
highlights IUGR fetuses with normal placental weights that
are still growth-retarded. The F/P ratio is decreased either in
IUGR with placental weight 250 g who are lactacidemic or
in IUGR fetuses with normal placental weight who are not
lactacidemic: we interpret this observation as being the result
of a reduction in placental mass which is inadequate to meet
fetal needs throughout gestation in the first group of fetuses
(low fetal weight, low placental weight) whereas in the second
group with normal placental weight (and low fetal weight) it
is likely that the functional capacity of the placenta (placental
function per gram of tissue) may be impaired.
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